The functions of resident macrophages (MO)' in hematopoietic and lymphoid organs are poorly understood . In several species, in situ immunocytochemical staining with MO-specific mAbs has demonstrated that these tissues contain large numbers of stromal MO, even in the absence of overt inflammation or immune stimulation (1-6). We and others have previously speculated that stromal MO may perform diverse local homeostatic functions, including regulation of growth, differentiation and movement of hematopoietic and lymphoid cells (7, 8) . Our experimental approach has been to isolate the relevant MO populations and determine whether they possess novel features that could be involved in cellular interactions .
To understand the nature and functions of SER, it would clearly be advantageous to raise an mAb to the receptor. The recent observation that high levels ofSER are induced on peritoneal MO cultivated in mouse serum provided us with a suitable source ofantigenic material and a rapid method for screening inhibitory mAbs (11) . In this paper we describe the isolation of mAb SER 4, characterize the molecular nature of SER, and determine its distribution on MO in various tissues .
Materials and Methods
staining, using 10% acrylamide gels under reducing and nonreducing conditions . Protein concentrations were determined by measuring absorbance at 280 nM, assuming an extinction coefficient of 1 .4 .
Comparison of SER Expression with SER-4 Ag . TPM were plated at 10 5/well in 96-well tissue culture microtiter plates in the defined serum-free medium, HB102 (New England Nuclear, Boston, MA) and allowed to adhere for 90 min . This and subsequent incubations were at 37°C and 5% C02 in a fully humidified incubator. Supernatants were removed and replaced with HB102 medium containing mouse serum at 20, 5, or 0% . SER assays were carried out in quadruplicate on days 0, 1, 2, and 4 . Rosettes were fixed in 0 .125% glutaraldehyde for 10 min and permeabilized in methanol for 30 min . The relative numbers of sheep E bound/well were determined by measuring the pseudoperoxidase activity of hemoglobin (17) , as follows . PBS containing 10 mM imidazole, 0 .5 mg/ml diaminobenzidine (DAB), and 0 .02% H202 (pH 7 .4), was added to wells . After 1 h at room temperature absorbance of the reaction product was measured at 410 nm on a Titertek plate reader (Dynatech Laboratories, Inc ., Alexandria, VA) .
To determine the number of cells in each well, the nuclei of methanol-fixed TPM in separate wells were stained for 1 min with 1% crystal violet in 70% methanol, followed by extensive rinsing with tap water. The absorbance at 570 nm was determined on the Titertek plate reader and converted to cell number using a linear standard curve, obtained by plating serial dilutions of TPM . The relative number of sheep E bound per MO was calculated and expressed as an E/MO index = OD (DAB)/OD (Crystal violet) .
The remaining wells on each row were used for determination of SER 4 Ag site number. Wells were rinsed with FCS, air dried, and the plates were stored desiccated at -20°C . Immediately before assay, TPM were fixed for 10 min in methanol and nonspecific binding sites blocked by incubation in 10% rat serum for 30 min . Wells were . incubated for 60 min at 4°C with 50 /Al of a predetermined saturating concentration (10 Wg/ml) of 125 1-SER4 Fab, specific activity 1 .3 fACi/lAg, labeled by the chloramine T method (18) . Specific binding was determined by subtracting counts from separate wells that had been preincubated with 30 Rg/ml unlabeled SER4 IgG before addition of 121 1-SER-4 Fab . As an internal control for site number analysis, binding assays were also carried out with ' 25 I-Fab fragments of the anti-CR3 mAb, 5C6, provided by Dr. H . Rosen (19) . Bound radioactivity was solubilized in 0 .5% NaCH and counted in a Packard 5210 gamma counter.
Immunocytochemistry. In preliminary experiments the antigenic determinant recognized by mAb SER4 was destroyed by the fixatives glutaraldehyde and paraformaldehyde but not ethanol, methanol, or acetone . 7-AM cryostat sections were therefore fixed for 10 min in acetone at room temperature and stained with a 1 :5 dilution of hybridoma tissue culture supernatant using an avidin-biotin-peroxidase detection kit (Vectastain; Vector Laboratories, Peterborough, UK) . Negative controls included omission of first antibody and use of rat mAbs directed to unrelated Ag .
Immunoprecipitation . 10' TPM were cultured for 2 d in 10-cm diameter tissue culture petri dishes at a concentration of 10 6 /ml in DME + 10% mouse serum . For metabolic labeling, the medium was changed to methionine-and cysteine-free Eagle's medium with 10% mouse serum that had been desalted into the same medium using PD-10 columns (Pharmacia Fine Chemicals) .
[ 35S]Methionine and ["S]cysteine were each added at 25 ACi/ml, final concentration, and the cells were incubated for a further 16 h . For surface labeling, TPM, adherent to 10-cm diameter dishes, were iodinated by the lactoperoxidase-glucose oxidase method for 30 min at 4°C (20) . After either method of labeling, TPM were washed extensively and solubilized in 10 mM Tris lysis buffer, pH 8 .0, containing 150 mM NaCl, 2% NP-40, 2 mM PMSF, 5 mM EDTA, 5 mM iodoacetamide, 100 FLg/ml soybean trypsin inhibitor, 1 ug/ml pepstatin, and 0 .5% BSA . Nuclei and other insoluble materials were removed by centrifugation at 10,000 g and immunoprecipitations carried out as described (19) . The samples were electrophoresed on 6.5% polyacrylamide gels according to Laemmli (21) . ' 4 C-methylated protein molecular weight markers (code CFA 626) were obtained from Amersham International PLC .
Western Blots. TPM were cultured for 3 d and lysates were prepared as described above . Spleen, mesenteric lymph nodes, thymus, and femoral bone marrow plugs were obtained from a single mouse and added to 1 ml of 10 mM Tris, pH 8.0, containing 150 mM NaCl and protease inhibitors . The tissues were disrupted using an electrically driven homogenizer (Polytron ; Kinematica GmbH, Lucerne, Switzerland) and solubilized by addition ofan equal volume of nonreducing 2 x SDS-PAGE sample buffer. Reduction with (3-mercaptoethanol resulted in loss of antigenic activity. After removal of insoluble material by centrifugation at 10,000 g, 35 ul of the lysates were electrophoresed on 6.5% polyacrylamide gels. Proteins were transferred to nitrocellulose as described (22) and probed with 0.5 t~g/ml "'I-SER-4 IgG, prepared by the chloramine T method (18) . Specificity was determined by comparing the signals obtained in the presence or absence of 100-fold excess of unlabeled SER 4 IgG .
Results
Isolation of an mAb Directed to SER. To obtain an mAb to SER, our strategy was to immunize rats,wlth mouse serum-induced TPM expressing high levels of SER, as determined by sheep E binding, and then to screen hybridoma supernatants for their ability to block sheep E binding to induced TPM (11) . From a total of four fusions, one positive hybridoma was identified and designated SER-4 . Tissue culture supernatant from SER-4 was able to completely inhibit binding of sheep E to mouse serum-induced TPM (Fig. 1 ). Complete inhibition of sheep E binding was also observed with resident bone marrow MO on which the hemagglutinin was first described (not shown). Inhibition of SER by SER-4 supernatant was not accompanied by visible signs of toxicity or changes in morphology.
SER-4 was cloned three times by limiting dilution and was found to secrete an mAb of the rat IgG2a subclass by Ouchterlony analysis . After purification, the intact immunoglobulin was able to inhibit sheep E binding completely at ti 1 /Ag/ml (Fig. 2) . In comparison, F(ab')2 fragments of SER 4 mAb gave a maximum of only 50-60% inhibition, while Fab fragments had no effect on rosetting, even at concentrations up to 100 Ftg/ml (Fig. 2) . The failure of Fab to inhibit binding of sheep E was not due to its lower avidity, since at 40 p,g/ml it completely inhibited binding of a saturating concontration (1 hg/ml) of SER4 IgG to TPM. In addition, 125I-SER-4 Fab bound to induced TPM in a specific and saturable manner, with maximal binding at 10 hg/ml (not shown).
Comparison ofExpression ofSER with the SER-4Ag Our previous studies have demonstrated that the in vitro expression of SER on TPM can be regulated reversibly by mouse serum in a dose-dependent fashion (11) . It was therefore of interest to compare the binding of sheep E with expression of the SER-4 Ag by TPM cultured in a range of mouse serum concentrations. Antigenic site number analysis was carried out by direct binding assay with "5 I-SER-4 Fab on methanol-fixed TPM . This measures the total amount ofSER-4 Ag, both intra-and extracellular. It can be seen in Fig . 3 that expression of SER and the SER-4 Ag were closely correlated throughout the course of the experiment. At the outset of culture, TPM bound an average of 4 x 104 SER4 Fab molecules/cell and there was negligible binding of sheep E. The highest levels ofboth SER-4 Ag and SER expression were observed on day 2 of culture in 20% mouse serum . At this time TPM bound an average of -10' SER-4 Fab molecules/cell, representing a 25-fold increase in antigenic site number. In comparison, levels of SER activity (sheep E binding) increased -10-fold . As an internal control for the site number analysis, binding assays were also carried out with Fab fragments of 5C6 anti CR3 mAb (19) . On day 2, TPM bound on average of 2 x 105 molecules of ' 25I-5C6-Fab, irrespective ofthe concentration of mouse serum used for culture. This is in agreement with previous estimates of CR3 site number on MO (23) . After removal of serum after 48 h, the levels of SER4 Ag and SER declined in parallel . These results support the notion that the Ag recognized by SER-4 mAb is either closely related to, or identical with, SER.
Characterization of the Antigen Recognized by mAb SER-4. After metabolic labeling of mouse serum-induced TPM with a mixture of [35 S]methionine and ["S]cysteine, mAb SER4 was found to immunoprecipitate two species of Ag determined by SDS-PAGE not seen with control mAb 1A10 (Fig . 4 A) . Under reducing conditions there was a major band with apparent Mr of -185 x 10 3 and a minor band at -175 x 103. Under nonreducing conditions, the apparent Mr of each band was decreased by -15 x 103 indicating the presence of one or more intrachain disulphide bonds. After t25I surface labeling of mouse serum-induced TPM, mAb SER-4 specifically immunoprecipitated a single species of Ag by SDS-PAGE, with an apparent Mr of -185 x 10 3 (reduced) (Fig . 4 B) or -170 x 10 3 (nonreduced) (not shown) . Since the lower Mr species observed after metabolic labeling was not detected with surface labeling, it is likely to be an incompletely processed form of the molecule that is absent from the plasma membrane .
To determine whether the SER4 Ag was one of the forms of the LC Ag (24) we carried out immunoprecipitations with a pan anti-LC mAb, M1/9 .3 (12) . Following surface labeling with 1211, the LC Ag ran under reducing conditions on SDS-PAGE as a broad band with a Mr ranging from 155 to 180 x 10 3. This was clearly distinct from the SER-4 Ag immunoprecipitated from the same lysate and run on the same gel (Fig . 4 B) . This demonstrates that the SER-4 Ag is not a member of the LC Ag family.
Distribution of SER-4 Ag In Vioo. In a previous study it was shown that expression of SER, assessed by rosette analysis, was restricted to certain subpopulations ofstromal tissue MO, especially those isolated from hematopoietic and lymphoid tissues. It was therefore important to compare the pattern of SER expression with the immunocytochemical distribution of SER4 Ag in various tissues.
First, in cryostat sections ofbone marrow plugs, mAb SER-4 revealed an arborizing network of stromal cells that were evenly distributed throughout the tissue (Fig. 5  A) . These cells had the morphological features of resident bone marrow MO (1, 6-8), and were intimately associated with hematopoietic cells. Immunofluorescence doublelabeling experiments with the MO-specific mAb, F4/80 (18), confirmed that SER-4 + cells were also F4/80+ (not shown) . However, bone marrow monocytes, which label with F4/80, were not stained by SER-4. The selectivity of mAb SER4 for the resident MO population is consistent with previous rosetting experiments in which the resident MO were shown to be the only bone marrow cells, including monocytes, able to bind sheep erythrocytes (9) . In lymph nodes, either mesenteric (Fig. 5 B) , cervical or popliteal (not shown), intense staining was observed on stromal MO in the subcapsular sinus and medullary cords, but tingible body MO present in follicles were not stained . In some follicles, however, SER-4 revealed a reticular staining pattern within the developing germinal centers . The anatomical location and appearance of this staining pattern suggest that follicular dendritic cells may also be SER 4+ (25) .
In the spleen, strong reactivity was observed on very stellate cells within the inner region of the marginal zone (Fig . 5 C) . Weaker, but easily detectable staining was also present on marginal zone and red pulp MO (Fig. 5 C) . Examination under high power showed that the most strongly staining cells were on the follicular side of the marginal sinus . They can therefore be identified as marginal metallophils, a specialized subpopulation of spleen MO (26, 27) . In support of this conclusion, we found that MOMA-1, a rat mAb that specifically recognizes mouse marginal metallophils (13) , produced a staining pattern in the spleen that was indistinguishable from that of SER-4 (not shown) . In contrast to the other lymphoid tissues, the thymus showed no detectable staining with SER-4 (not shown) .
In the liver, Kupffer cells were found to stain weakly, but uniformly with SER-4
( Fig . 5 D) . In the lung, the stellate interstitial MO stained strongly with SER-4 and a subpopulation of bronchoalveolar MO was also positive (not shown). In the skin, no reactivity was observed on epidermal Langerhans cells, though scattered dermal histiocytes were strongly positive (not shown). In the small intestine, occasional MO in the lamina propria were stained and stromal MO underlying the dome epithelium of Peyer's patches were also positive (not shown). In the kidney, virtually no MO or other cell populations reacted with SER-4 (not shown). Finally, in the brain, microglia in the white and grey matter were completely negative for SER4. Interestingly, however, the majority of MOB outside the blood brain barrier (28) , in the choroid plexus, pituitary gland, subfornical organ, and leptomeninges, were clearly positive (not shown). Nature of SER-4 Ag in Tissues. Western blot analyses were carried out to determine the nature of the Ag recognized by mAb SER-4 in hematopoietic and lymphoid tissues (Fig. 6 ). With nonreduced lysates ofmouse serum-induced TPM, used as a control, 125 1-SER-4 IgG specifically bound a 170-kD molecule (Fig. 6 ). Indistinguishable bands at 170 kD were seen for spleen, lymph node, and bone marrow, but no band was visible in the thymus (Fig. 6) . The rank order (normalized on an organ, rather than cell number basis) was lymph node > spleen > bone marrow. The relative amount of SER-4 Ag for each tissue is therefore in agreement with the overall intensity of staining observed by immunocytochemistry.
Discussion
In this study we described the isolation and characterization of an mAb directed to SER, a novel MO receptor that binds unopsonized sheep E via recognition of sialylated glycoconjugates (9) . Our strategy, to screen for mAbs that inhibit receptor function, is a powerful selection method that has been used previously to isolate mAbs to FcR, fibronectin receptor, and other adhesion receptors on MO (19, 29, 30) .
Several lines of evidence indicate that the molecule recognized by mAb SER4 is equivalent to SER, defined previously by rosetting studies . First, the time course of expression of the Ag on peritoneal MO cultured in mouse serum closely parallels that of SER . Second, the distribution of the Ag in situ is consistent with previous rosetting studies of SER expression on isolated tissue MO populations (9) . Third, recent experiments in our laboratory indicate that the purified molecule specifically agglutinates sheep E (Crocker, P., unpublished observations) .
It is likely that mAb SER 4 is directed close to, but not at, the putative sialic acid binding site of the receptor, since only 50% inhibition was obtained with F(ab')2 fragments while Fab fragments had no effect on SER function, despite binding effectively to the SER4 Ag. This pattern of inhibition is compatible with steric hindrance such that the degree of inhibition is proportional to the size of the mAb fragment .
However, we cannot exclude a partial role for MO Fc receptors in mediating the inhibition by intact IgG .
The molecular properties and tissue distribution of the SER4 Ag suggest that it is a previously uncharacterized differentiation Ag of mononuclear phagocytes . Immunoprecipitation and Western blotting experiments demonstrated that the SER-4
Ag is synthesized by MO as a single-chain plasma membrane protein that on SDS-PAGE has an apparent Mr of 185 x 103 under reducing conditions and 170 x 103 under nonreducing conditions . Despite the similarity in Mr to the LC Ag family of molecules, the SER-4 Ag was shown to be distinct from members of this family expressed on the same MO (24) . The SER-4 Ag is of similar Mr to several other single chain lectin-like receptors present in eukaryotic cells. These include the mannose receptor (175 kD) and the cation-independent mannose-6-phosphate receptor (215 kD), both of which are expressed on MO as well as other cell types (31) (32) (33) . However, SER can be distinguished from both molecules on the bases of ligand specificity, behavior on SDS-PAGE, and tissue distribution (31) (32) (33) .
The SER-4 Ag was found to be present at high levels on subpopulations of stromal tissue macrophages. The pattern of expression was in agreement with earlier sheep E rosetting assays for SER (9) . Thus, in the bone marrow, SER-4 Ag was restricted to the resident bone marrow MO population, with none being detected on the developing F4/80+ monocytes. Particularly striking was the high level of expression by the majority of stromal MO in lymph nodes that also rosette intensely with sheep E (9) . The spleen showed a more complex pattern of reactivity for SER-4, with high levels observed only on marginal metallophils. Lesser, but clear staining was detected on MO in the red pulp and the outer marginal zone. Since the majority of stromal MO isolated from the spleen by collagenase digestion are from the red pulp and marginal zone (34, 35) , the immunocytochemical staining pattern observed in the present study is consistent with previous rosetting analyses in which isolated stromal spleen MO expressed moderate levels of SER (9) .
Site number analysis ofSER expression by TPM cultured in mouse serum showed that an average of up to 106 molecules of SER-4 Ag were expressed per cell . Although N50% of this is intracellular (Crocker, P, unpublished observations), it is clear that when compared with other well-characterized plasma membrane receptors such as mannose receptor, CR3 and FcR, SER is potentially one of the most highly expressed MO-restricted surface molecules described to date .
How can the heterogeneity ofSER expression on MO populations be explained? We have recently demonstrated that the induction and maintenance of SER on MO in vitro is regulated in a dose-dependent manner by a species-restricted activity in mouse plasma and lymph (11) . The activity in plasma had an apparent M, of -70 x 103 by gel filtration and this led us to propose that the heterogeneity of SER expression on different MO populations could in part be explained by the relative concentration of inducing activity in different tissue compartments . In the present study, clear evidence for this possibility was seen in the central nervous system, where microglia within the blood brain barrier expressed no detectable SER-4 Ag, whereas MO outside the blood brain barrier, in the choroid plexus and subfornical organ, expressed relatively high levels (28) . Likewise, the absence ofthe SER4 Ag on thymic MO may be related to the presence of nonleaky endothelium in the cortex of this organ, creating a "blood-thymus barrier" (36) .
It is clear, however, that there are additional mechanisms that regulate the level of the SER-4 Ag, because sinus-lining MO in liver and spleen express intermediate levels, although they are continuously exposed to plasma . Since these MO populations are important in the removal of effete E and since circulating mouse E express a sialylated ligand for SER (Crocker, P, unpublished observations), ingestion of effete E by these MO could result in internalization and degradation of the SER4 Ag.
The availability of an inhibitory mAb to SER will be a valuable tool in future studies investigating the functional significance ofthe receptor on MO populations. The distribution of SER on selected populations ofstromal tissue MO is consistent with a role in cell-cell or cell-matrix interactions . Unlike other well-defined MO lectinlike receptors, such as the mannose and galactose receptors (37, 38) , SER does not mediate phagocytosis of ligand-bearing particles and its primary function is therefore unlikely to be related to scavenging. IfSER is involved in adhesive interactions in tissues such as bone marrow and lymph nodes, it should be possible to identify ligands on cells that are naturally associated with SER4' stromal MO. Direct support for this possibility has come from our recent studies in which subpopulations of mouse bone marrow cells were shown to bind stably to SER + MOB in a manner indistinguishable from that of sheep E (Crocker, P., unpublished observations) . In lymph nodes, SER4+ MO in subcapsular sinuses and medullary cords interact with recirculating lymphocytes and plasma cells, respectively (25) , and marginal metallophils of the spleen are thought to bind avidly to B lymphocytes (27) .
It is therefore possible that SER contributes to local adhesive interactions that influence the movement of bone marrow cells and recirculation of lymphocytes . In addition, the finding that sialic acid binding proteins can be mitogenic for B and T lymphocytes raises the interesting possibility that SER is involved in growth regulation of attached cells via direct cellular signaling (39, 40) .
Summary
An inhibitory rat mAb, SER4, has been raised to the mouse macrophage (MO)-restricted hemagglutinin, sheep erythrocyte receptor (SER), which binds unopsonized sheep erythrocytes through recognition of sialylated glycoconjugates . This receptor was originally defined on mouse resident bone marrow MO where it was implicated in adhesive interactions of these cells with proliferating hematopoietic cells . In the present study using mouse serum-induced thioglycollate-elicited peritoneal MO (TPM) as a model system for SER expression, mAb SER-4 IgG2a completely blocked rosette formation at 1 Ftg/ml . The inhibition was likely to be via steric hindrance rather than through a direct interaction with the putative sialic acid binding site of SER because F(ab')2 and Fab fragments of mAb SER4 gave a maximum inhibition of 50-60% and Oolo respectively, despite binding effectively to the SER4 antigen (Ag). Immunoprecipitation and Western blotting experiments with cultured MOB or tissue extracts demonstrated that the Ag recognized by SER4 mAb is a single chain molecule with an apparent Mr by SDS-PAGE of 185 x 103 (reduced) or 170 x 103 (nonreduced) and is distinct from members ofthe leukocyte common Ag family. Expression of SER and SER-4 Ag in culture were closely correlated and depended on the presence of mouse serum for optimal induction . Further evidence that the SER-4 Ag is functionally equivalent to SER was provided by immunocytochemistry in which the overall pattern of staining in tissues was consistent with previous rosetting experiments . In the bone marrow, expression of the SER4 Ag was restricted to the resident bone marrow MAD population with no expression on monocytes. High expression was also observed on stromal MO within the subcapsular sinus and medullary cords in lymph nodes and on marginal metallophils in the spleen . These results therefore confirm that SER is a novel MO-restricted receptor whose distribution and properties indicate a role in cellular interactions in hematopoietic and lymphoid tissues .
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